Lead Product(s): RLS-0071
Therapeutic Area: Neurology Product Name: Undisclosed
Highest Development Status: IND Enabling Product Type: Large molecule
Partner/Sponsor/Collaborator: Children’s Research Holdings
Deal Size: $14.0 million Upfront Cash: Undisclosed
Deal Type: Series A Financing April 21, 2020
Proceeds will fund advancement of programs addressing acute lung injury due to COVID-19 and severe birth asphyxia (HIE).